<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><?release-delay 0|0 ?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id><journal-id journal-id-type="hwp">jbc</journal-id><journal-id journal-id-type="pmc">jbc</journal-id><journal-id journal-id-type="publisher-id">JBC</journal-id><journal-title-group><journal-title>The Journal of Biological Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0021-9258</issn><issn pub-type="epub">1083-351X</issn><publisher><publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name><publisher-loc>9650 Rockville Pike, Bethesda, MD 20814, U.S.A.</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19628875</article-id><article-id pub-id-type="publisher-id">M109.017566</article-id><article-id pub-id-type="doi">10.1074/jbc.M109.017566</article-id><article-categories><subj-group subj-group-type="heading"><subject>Protein Structure and Folding</subject></subj-group></article-categories><title-group><article-title>Structure of Signal-regulatory Protein &#x003b1;</article-title><subtitle>A LINK TO ANTIGEN RECEPTOR EVOLUTION<xref ref-type="fn" rid="FN1">*</xref><xref ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref></subtitle></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hatherley</surname><given-names>Deborah</given-names></name><xref ref-type="aff" rid="aff1"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Graham</surname><given-names>Stephen C.</given-names></name><xref ref-type="aff" rid="aff2"><sup>&#x000a7;</sup></xref><xref ref-type="author-notes" rid="FN3"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Harlos</surname><given-names>Karl</given-names></name><xref ref-type="aff" rid="aff2"><sup>&#x000a7;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Stuart</surname><given-names>David I.</given-names></name><xref ref-type="aff" rid="aff2"><sup>&#x000a7;</sup></xref><xref ref-type="corresp" rid="cor1"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Barclay</surname><given-names>A. Neil</given-names></name><xref ref-type="aff" rid="aff1"><sup>&#x02021;</sup></xref><xref ref-type="corresp" rid="cor2"><sup>3</sup></xref></contrib><aff id="aff1">From the <label>&#x02021;</label>Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom and </aff><aff id="aff2">the <label>&#x000a7;</label>Division of Structural Biology and Oxford Protein Production Facility, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom</aff></contrib-group><author-notes><corresp id="cor1"><label>2</label> To whom correspondence may be addressed: <addr-line>Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom.</addr-line> Tel.: <phone>441865287546</phone>; Fax: <fax>441865287547</fax>; E-mail: <email>dave@strubi.ox.ac.uk</email>.</corresp><corresp id="cor2"><label>3</label> To whom correspondence may be addressed: <addr-line>Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, United Kingdom.</addr-line> Tel.: <phone>441865275598</phone>; Fax: <fax>441865275591</fax>; E-mail: <email>neil.barclay@path.ox.ac.uk</email>.</corresp><fn id="FN3" fn-type="other"><label>1</label><p>A Nuffield Medical Fellow.</p></fn></author-notes><pub-date pub-type="ppub"><day>25</day><month>9</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>23</day><month>7</month><year>2009</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>7</month><year>2009</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>284</volume><issue>39</issue><fpage>26613</fpage><lpage>26619</lpage><history><date date-type="received"><day>8</day><month>5</month><year>2009</year></date><date date-type="rev-recd"><day>18</day><month>6</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; 2009 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement><license license-type="open-access"><license-p><italic>Author's Choice</italic>&#x02014;Final version full access.</license-p><license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution Non-Commercial License</ext-link> applies to Author Choice Articles</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zbc03909026613.pdf"/><abstract><p>Signal-regulatory protein &#x003b1; (SIRP&#x003b1;) is a myeloid membrane receptor that interacts with the membrane protein CD47, a marker of self. We have solved the structure of the complete extracellular portion of SIRP&#x003b1;, comprising three immunoglobulin superfamily domains, by x-ray crystallography to 2.5 &#x0212b; resolution. These data, together with previous data on the N-terminal domain and its ligand CD47 (possessing a single immunoglobulin superfamily domain), show that the CD47-SIRP&#x003b1; interaction will span a distance of around 14 nm between interacting cells, comparable with that of an immunological synapse. The N-terminal (V-set) domain mediates binding to CD47, and the two others are found to be constant (C1-set) domains. C1-set domains are restricted to proteins involved in vertebrate antigen recognition: T cell antigen receptors, immunoglobulins, major histocompatibility complex antigens, tapasin, and &#x003b2;2-microglobulin. The domains of SIRP&#x003b1; (domains 2 and 3) are structurally more similar to C1-set domains than any cell surface protein not involved in antigen recognition. This strengthens the suggestion from sequence analysis that SIRP is evolutionarily closely related to antigen recognition proteins.</p></abstract></article-meta></front><body><p>Signal-regulatory protein &#x003b1; (SIRP&#x003b1;)<xref ref-type="fn" rid="FN4"><sup>4</sup></xref> is a membrane receptor present on myeloid cells and neurons that interacts with the widely distributed cell surface protein CD47 (reviewed in Refs. <xref ref-type="bibr" rid="B1">1</xref> and <xref ref-type="bibr" rid="B2">2</xref>). Absence of CD47 leads to uptake of cells via macrophages, indicating that CD47 acts as a marker of self (<xref ref-type="bibr" rid="B3">3</xref>). SIRP&#x003b1; gives inhibitory signals through immunoreceptor tyrosine-based inhibition motifs in the cytoplasmic region that interact with phosphatases SHP-1 and SHP-2 (<xref ref-type="bibr" rid="B4">4</xref>). Binding of the N-terminal immunoglobulin superfamily (IgSF) V-set domain of SIRP&#x003b1; (SIRP&#x003b1; d1) to the single IgSF domain of CD47 is mediated by the loops of the SIRP&#x003b1; IgSF domain, analogous to the interactions mediated by antigen receptors, albeit involving only a single domain (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). This type of binding distinguishes the CD47-SIRP&#x003b1; interaction from that of many interactions at the cell surface involving IgSF domains such as CD2-CD58, where the face of the IgSF domain is involved (<xref ref-type="bibr" rid="B7">7</xref>). SIRP&#x003b1; domains 2 and 3 (d2 and d3) show amino acid sequence similarity to IgSF C1-set domains (<xref ref-type="bibr" rid="B8">8</xref>). Since IgSF C1-set domains have only been confirmed in vertebrate antigen receptors and associated proteins (Ig light and heavy chains, T cell receptor chains, MHC class I and II and related proteins, &#x003b2;2-microglobulin, and very recently tapasin (<xref ref-type="bibr" rid="B9">9</xref>)) of the vertebrate adaptive immune system, it was suggested that SIRP&#x003b1; might have evolved from a precursor of the antigen receptors (<xref ref-type="bibr" rid="B8">8</xref>).</p><p>We describe here the crystal structure of the full three-domain extracellular region of SIRP&#x003b1;, revealing that the topology of the CD47-SIRP&#x003b1; interaction is compatible with productive engagement occurring when cells come together in synapse-like contacts. We show that the two membrane-proximal IgSF domains are particularly close in structure to C1-set IgSF domains. This, together with the presence of an IgSF V-set domain mediating ligand recognition, suggests that SIRP&#x003b1; is related to a key precursor in the evolution of vertebrate antigen receptors.</p><sec sec-type="methods"><title>EXPERIMENTAL PROCEDURES</title><p>Recombinant extracellular SIRP&#x003b1; comprising the 30-residue N-terminal leader sequence and all three extracellular domains (residues 1&#x02013;319 of the mature protein; accession number <ext-link ext-link-type="gen" xlink:href="CAA71403">CAA71403</ext-link>) followed by the sequence TRHHHHHH was produced, deglycosylated, and crystallized as for SIRP&#x003b1; d1 (<xref ref-type="bibr" rid="B6">6</xref>). Crystallization experiments were performed in 96-well nanoliter-scale sitting drops (100 nl of 18.6 mg/ml SIRP&#x003b1; d1&#x02013;d3 plus 100 nl of precipitant) equilibrated at either 5 or 20.5 &#x000b0;C against 95-&#x003bc;l reservoirs of precipitant and were monitored via an automated storage and imaging system (<xref ref-type="bibr" rid="B10">10</xref>). Diffraction quality crystals grew at 20.5 &#x000b0;C against a reservoir of 1.0 <sc>m</sc> trisodium citrate, 0.1 <sc>m</sc> sodium cacodylate, pH 6.5, within 2 weeks. Crystals were cryoprotected by a quick sweep through perfluoropolyether PFO-X125/03 (Lancaster Synthesis) before being flash-cryocooled by transfer directly into a cold stream of nitrogen gas (100 K). Diffraction data were recorded from a single frozen (100 K) crystal of SIRP&#x003b1; d1&#x02013;d3 at European Synchrotron Radiation Facility beamline ID14-2 (&#x003bb; = 0.933 &#x0212b;) on an ADSC Quantum4R CCD detector. Diffraction data were indexed, integrated, and scaled using XDS (<xref ref-type="bibr" rid="B11">11</xref>) and SCALA (<xref ref-type="bibr" rid="B12">12</xref>) via the xia2 automated data processing pipeline<xref ref-type="fn" rid="FN5"><sup>5</sup></xref> (<xref ref-type="table" rid="T1">Table 1</xref>).</p><p>The structure of SIRP&#x003b1; d1&#x02013;d3 was solved by molecular replacement using MOLREP (<xref ref-type="bibr" rid="B13">13</xref>), the structures of SIRP&#x003b1; d1 (Protein Data Bank code <ext-link ext-link-type="pdb" xlink:href="2uv3">2uv3</ext-link>), the light chain constant domain of monoclonal antibody YTS 105.18 (Protein Data Bank code <ext-link ext-link-type="pdb" xlink:href="2ajr">2ajr</ext-link>), and the &#x003b1;3 domain of rat MHC class I (Protein Data Bank code <ext-link ext-link-type="pdb" xlink:href="1ed3">1ed3</ext-link>) being used as search models for domains 1, 2, and 3, respectively. Manual model building was performed in COOT (<xref ref-type="bibr" rid="B14">14</xref>), and the model was refined using a combination of phenix.refine (<xref ref-type="bibr" rid="B15">15</xref>) for coordinate refinement and BUSTER/TNT (<xref ref-type="bibr" rid="B16">16</xref>) for refinement of <italic>B</italic> values (<xref ref-type="bibr" rid="B17">17</xref>). At all stages, building and refinement were informed by the validation tools present in COOT and by the MolProbity Web server (<xref ref-type="bibr" rid="B18">18</xref>).</p><p>Searches for similar protein structures were performed using the protein structure comparison service SSM at the European Bioinformatics Institute (<xref ref-type="bibr" rid="B19">19</xref>) against the IgSF domain subsets present in version 1.73 of the SCOP data base (<xref ref-type="bibr" rid="B20">20</xref>), using default parameters. SIRP&#x003b1; d1, d2, and d3 (residues 1&#x02013;114, 115&#x02013;220, and 221&#x02013;317, respectively) were used as query structures. Additional query structures were CD80 d2 (SCOP domain d1dr9a2), VCAM-1 d2 (SCOP domain d1vscc1), constant domains (d2) of MHC class II &#x003b2; chain (SCOP domain d1s9ve1) and of Ig &#x003ba; (Protein Data Bank code <ext-link ext-link-type="pdb" xlink:href="1q9l">1q9l</ext-link> chain L residues 109&#x02013;221), lutheran d2 (Protein Data Bank code <ext-link ext-link-type="pdb" xlink:href="2pet">2pet</ext-link> chain A residues 115- 231), and tapasin d2 (Protein Data Bank code <ext-link ext-link-type="pdb" xlink:href="3f8u">3f8u</ext-link> chain B residues 270&#x02013;381). Representative V-, C1-, C2-, and I-set IgSF domains (non-redundant at a level of 70% sequence identity, 271 structures in total) were extracted from the SCOP data base with the assistance of the ASTRAL compendium (<xref ref-type="bibr" rid="B21">21</xref>). Pairwise superposition of the 271 representative IgSF domains plus SIRP&#x003b1; d1&#x02013;d3; d1 from SIRP&#x003b2;, -&#x003b2;(2), and -&#x003b3;; CD80 d2; VCAM-1 d2; MHC class II &#x003b2; chain d2; Ig &#x003ba; d2; lutheran d2; and tapasin d2 was performed using SSM. A metric for defining the relatedness of domains was obtained using <xref ref-type="disp-formula" rid="FD1">Equation 1</xref>, <disp-formula id="FD1"><graphic xlink:href="zbc03909-8941-m01"/></disp-formula> where <italic>R</italic> represents the relatedness, <italic>D</italic> is the C&#x003b1; r.m.s. deviation of the two domains, &#x02329;<italic>n</italic>&#x0232a; is the mean number of residues in the two domains, and <italic>M</italic> is the number of structurally equivalent C&#x003b1; atoms. A two-dimensional graph depicting the relatedness of IgSF domains, where edges (lines) connecting highly related structures are short and edges connecting unrelated structures are long, was generated from the matrix of 283 &#x000d7; 282 relatedness values using the Fruchterman-Reingold graph layout algorithm (<xref ref-type="bibr" rid="B22">22</xref>) as implemented by CLANS (<xref ref-type="bibr" rid="B23">23</xref>) with default parameters. Results depicted are representative of multiple minimizations with random initial starting conditions. For illustrations, multiple structures were superposed using Theseus (<xref ref-type="bibr" rid="B24">24</xref>), and molecular graphics were prepared using PyMOL (DeLano Scientific).</p></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Crystallization and Structure Determination</title><p>The extracellular region of SIRP&#x003b1; was expressed in a mutant Chinese hamster ovary cell line with defective glycosylation machinery that renders glycoproteins sensitive to endoglycosidase H treatment and more homogenous, thereby promoting crystallization (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). Crystals of deglycosylated SIRP&#x003b1; were obtained by sitting drop vapor diffusion, and diffraction data were recorded to 2.5 &#x0212b; (<xref ref-type="table" rid="T1">Table 1</xref>). The structure was solved by molecular replacement using the N-terminal V-set domain of SIRP&#x003b1; (Protein Data Bank code <ext-link ext-link-type="pdb" xlink:href="2uv3">2uv3</ext-link>) and the C1-set domains of an Fab light chain (Protein Data Bank code <ext-link ext-link-type="pdb" xlink:href="2ajr">2ajr</ext-link>) and an MHC class I &#x003b1;3 domain (Protein Data Bank code <ext-link ext-link-type="pdb" xlink:href="1ed3">1ed3</ext-link>) as starting models for domains 1&#x02013;3, respectively. The structure has been refined to 2.5 &#x0212b; resolution with residuals <italic>R</italic> = 21.8% and <italic>R</italic><sub>free</sub> = 27.1% (<xref ref-type="table" rid="T1">Table 1</xref>).</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p><bold>Data collection and refinement statistics</bold></p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Parameters</th><th align="center" rowspan="1" colspan="1">Values</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1"><bold>Data collection</bold></td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Resolution limits (&#x0212b;)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td><td align="char" char="(" rowspan="1" colspan="1">38.1-2.5 (2.55-2.49)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Space group</td><td align="center" rowspan="1" colspan="1"><italic>P</italic>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Unit cell dimensions (&#x0212b;)</td><td align="center" rowspan="1" colspan="1">47.4, 84.4, 98.9</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Unique reflections<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td><td align="char" char="(" rowspan="1" colspan="1">14,246 (1,037)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Redundancy<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td><td align="char" char="(" rowspan="1" colspan="1">4.8 (4.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Completeness (%)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td><td align="char" char="(" rowspan="1" colspan="1">98.5 (98.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<italic>I</italic>/&#x003c3;(<italic>I</italic>)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td><td align="char" char="(" rowspan="1" colspan="1">14.2 (2.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<italic>R</italic><sub>merge</sub> (%)<sup><xref ref-type="table-fn" rid="TF1-1"><italic>a</italic></xref>,<xref ref-type="table-fn" rid="TF1-2"><italic>b</italic></xref></sup></td><td align="char" char="(" rowspan="1" colspan="1">6.9 (85.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<italic>R</italic><sub>meas</sub> (%)<sup><xref ref-type="table-fn" rid="TF1-1"><italic>a</italic></xref>,<xref ref-type="table-fn" rid="TF1-3"><italic>c</italic></xref></sup></td><td align="char" char="(" rowspan="1" colspan="1">7.7 (95.7)</td></tr><tr><td colspan="2" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Refinement</bold></td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Resolution limits (&#x0212b;)<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td><td align="char" char="(" rowspan="1" colspan="1">27.0-2.5 (2.64-2.49)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;No. of reflections in working set<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td><td align="char" char="(" rowspan="1" colspan="1">14,207 (2,133)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;No. of reflections in test set<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></td><td align="char" char="(" rowspan="1" colspan="1">692 (106)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<italic>R</italic><sub>xpct</sub> (%)<sup><xref ref-type="table-fn" rid="TF1-1"><italic>a</italic></xref>,<xref ref-type="table-fn" rid="TF1-4"><italic>d</italic></xref></sup></td><td align="char" char="(" rowspan="1" colspan="1">21.8 (28.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<italic>R</italic><sub>free</sub> (%)<sup><xref ref-type="table-fn" rid="TF1-1"><italic>a</italic></xref>,<xref ref-type="table-fn" rid="TF1-5"><italic>e</italic></xref></sup></td><td align="char" char="(" rowspan="1" colspan="1">27.1 (32.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;No. of atoms (protein/carbohydrate/water)</td><td align="center" rowspan="1" colspan="1">2,350/14/49</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Residues in Ramachandran favored region (%)</td><td align="char" char="." rowspan="1" colspan="1">98.7</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Ramachandran outliers (%)</td><td align="char" char="." rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;r.m.s. bond lengths (&#x0212b;)</td><td align="char" char="." rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;r.m.s. bond angles (degrees)</td><td align="char" char="." rowspan="1" colspan="1">0.875</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Average <italic>B</italic> factors (&#x0212b;<sup>2</sup>) (protein/carbohydrate/water)</td><td align="center" rowspan="1" colspan="1">62.7/85.1/54.9</td></tr></tbody></table><table-wrap-foot><fn id="TF1-1"><p><italic><sup>a</sup></italic> Numbers in parentheses refer to the highest resolution shell.</p></fn><fn id="TF1-2"><p><italic><sup>b</sup> R</italic><sub>merge</sub> = 100 &#x000d7; (&#x003a3;<italic><sub>hkl</sub></italic>&#x003a3;<italic><sub>i</sub></italic>|<italic>I</italic>(<italic>hkl</italic>;<italic>i</italic>) &#x02212; &#x02329;<italic>I</italic>(<italic>hkl</italic>)&#x0232a;|/&#x003a3;<italic><sub>hkl</sub></italic>&#x003a3;<italic><sub>i</sub>I</italic>(<italic>hkl</italic>;<italic>i</italic>)), where <italic>I</italic>(<italic>hkl</italic>;<italic>i</italic>) is the intensity of an individual measurement of a reflection, and &#x02329;<italic>I</italic>(<italic>hkl</italic>)&#x0232a; is the average intensity of that reflection.</p></fn><fn id="TF1-3"><p><italic><sup>c</sup> R</italic><sub>meas</sub> is the redundancy-independent merging <italic>R</italic> factor (<xref ref-type="bibr" rid="B40">40</xref>). <italic>R</italic><sub>meas</sub> = 100 &#x000d7; (&#x003a3;<italic><sub>hkl</sub></italic>((<italic>n</italic>(<italic>hkl</italic>)/(<italic>n</italic>(<italic>hkl</italic>) &#x02212; 1))&#x000bd; &#x003a3;<italic><sub>i</sub></italic>|<italic>I</italic>(<italic>hkl</italic>;<italic>i</italic>) &#x02212; &#x02329;<italic>I</italic>(<italic>hkl</italic>)&#x0232a;|)/&#x003a3;<italic><sub>hkl</sub></italic>&#x003a3;<italic><sub>i</sub>I</italic>(<italic>hkl</italic>;<italic>i</italic>)), where <italic>n</italic> is the number of times a given reflection has been observed.</p></fn><fn id="TF1-4"><p><italic><sup>d</sup> R</italic><sub>xpct</sub> = 100 &#x000d7; (&#x003a3;<italic><sub>hkl</sub></italic>(&#x02016;<italic>F<sub>o</sub></italic>(<italic>hkl</italic>)| &#x02212; |<italic>F</italic><sub>xpct</sub>(<italic>hkl</italic>)&#x02016;)/&#x003a3;<italic><sub>hkl</sub></italic>|<italic>F<sub>o</sub></italic>(<italic>hkl</italic>)|), where |<italic>F<sub>o</sub></italic>(<italic>hkl</italic>)| and |<italic>F</italic><sub>xpct</sub>(<italic>hkl</italic>)| are the observed structure facture amplitude and the expectation of the model structure factor amplitude, respectively (<xref ref-type="bibr" rid="B16">16</xref>).</p></fn><fn id="TF1-5"><p><italic><sup>e</sup> R</italic><sub>free</sub> equals <italic>R</italic><sub>xpct</sub> of test set (5% of the data not used during refinement).</p></fn></table-wrap-foot></table-wrap></sec><sec><title>The Structure of the Extracellular Region of SIRP&#x003b1;</title><p>The extracellular region of SIRP&#x003b1; is shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>. The final refined structure comprises residues 1 (Glu) to 317 (Lys), the loops between residues 65&#x02013;67 (d1) and 288&#x02013;294 (d3) being excluded from the model due to the absence of well resolved electron density, presumably arising from disorder. An <italic>N</italic>-acetylglucosamine adduct was observed attached to the side chain of residue Asn<sup>239</sup>. Residual electron density consistent with the presence of <italic>N</italic>-linked carbohydrate was also evident at residue Asn<sup>214</sup>, but the electron density was not sufficiently well resolved to allow modeling of the carbohydrate moiety. As in previous determinations of the SIRP&#x003b1; d1 structure, no electron density was observed for <italic>N</italic>-acetylglucosamine at Asn<sup>80</sup>. The side chains of the other two potential glycosylation sites, Asn<sup>261</sup> and Asn<sup>288</sup>, were not sufficiently well resolved to determine their glycosylation states. The N-terminal domain (d1) of the three-domain SIRP&#x003b1; structure can be superposed on the higher resolution (1.85 &#x0212b;) structure of SIRP&#x003b1; in complex with CD47 with 1.1 &#x0212b; r.m.s. deviation over 111 C&#x003b1; atoms (residues 1&#x02013;114, excluding residues 65&#x02013;67 not observed in electron density). This allows the topology of the interaction to be determined (see below). In addition, there are now seven independent structures for SIRP&#x003b1; d1, which, when overlaid, illustrate the previously noted flexibility in the CC&#x02032;, C&#x02032;D, DE, and FG loops (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.017566/DC1">supplemental Fig. S1</ext-link>) (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). Excluding these loops and the first residue, all SIRP&#x003b1; d1 structures overlay extremely well (0.4 &#x0212b; r.m.s. deviation over 101 C&#x003b1; atoms).</p><fig id="F1" position="float"><label>FIGURE 1.</label><caption><p><bold>Structure of the extracellular region of SIRP&#x003b1;</bold>. <italic>A</italic>, the extracellular region of SIRP&#x003b1; is shown in <italic>ribbon representation colored</italic> from <italic>blue</italic> (N terminus) to <italic>red</italic> (C terminus). Disulfide bonds are shown as <italic>yellow spheres</italic>, the observed <italic>N</italic>-acetylglucosamine moiety is shown as <italic>magenta sticks</italic>, and other potential sites of <italic>N</italic>-linked glycosylation are indicated with <italic>magenta spheres. B</italic>, secondary structure is shown <italic>above</italic> the sequence of the three IgSF domains of SIRP&#x003b1;, <italic>arrows</italic> and <italic>cylinders</italic> representing &#x003b2; sheets and &#x003b1; helices, respectively. Residues not modeled due to poorly defined electron density are in <italic>lowercase type</italic>, the cysteine residues that form disulfide bond between &#x003b2; sheets are <italic>highlighted</italic> in <italic>yellow</italic>, the residue where <italic>N</italic>-linked glycosylation was observed in electron density is <italic>colored magenta</italic>, and other potential sites of <italic>N</italic>-linked glycosylation are <italic>outlined</italic> in <italic>magenta</italic>.</p></caption><graphic xlink:href="zbc0420989410001"/></fig><p>Domains 2 and 3 (d2 and d3) of SIRP&#x003b1; adopt typical IgSF folds, with eight &#x003b2; strands in two sheets linked by the canonical disulfide bond (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Both domains are more closely related in structure to each other than to SIRP&#x003b1; d1, superposing with 2.1 &#x0212b; r.m.s. deviation over 77 C&#x003b1; atoms <italic>versus</italic> 2.9 and 2.8 &#x0212b; r.m.s. deviation over 77 and 69 C&#x003b1; atoms when superposing d1 onto d2 and d3, respectively. Strands ABE and GFC of the two &#x003b2; sheets overlay extremely well (<xref ref-type="fig" rid="F2">Fig. 2</xref>), although a single residue &#x0201c;insertion&#x0201d; and the presence of a proline residue causes a slight &#x0201c;bulge&#x0201d; immediately preceding the shorter strand A in d2. Strands C&#x02032; and D are markedly different in length between the two domains, d3 having an unusually long C&#x02032; strand and a short D strand. The conformations of the loops between &#x003b2; strands AB, C&#x02032;D, DE, and FG differ significantly between the two domains, and the electron density of the EF loop in d3 is too poorly resolved to be modeled. Interestingly, the conformations of the loops linking strands B and C&#x02032; to strand C are very well conserved between d2 and d3. Sequence and structural conservation of the BC loop is a hallmark of IgSF C1-set domains, and it appears that SIRP&#x003b1; d2 and d3 are indeed members of this subset of IgSF domains (discussed below).</p><fig id="F2" position="float"><label>FIGURE 2.</label><caption><p><bold>Superposition of SIRP&#x003b1; domains 2 and 3.</bold> The superposed structures of SIRP&#x003b1; d2 (residues 115&#x02013;220; <italic>green</italic>) and d3 (residues 221&#x02013;317; <italic>orange</italic>) are displayed as <italic>ribbons</italic>. The short C&#x02032; strand of d2 and short D strand of d3 are marked with <italic>green</italic> and <italic>orange asterisks</italic>, respectively.</p></caption><graphic xlink:href="zbc0420989410002"/></fig></sec><sec><title>Topology of the CD47-SIRP&#x003b1; Interaction at the Cell Surface</title><p>The new structure for the full extracellular region of SIRP&#x003b1; together with the previous structure of the complex between SIRP&#x003b1; d1 and CD47 allows the topology of the full CD47-SIRP&#x003b1; interaction to be visualized (<xref ref-type="fig" rid="F3">Fig. 3</xref>). The overall dimensions of the modeled complex are 13.7 &#x000d7; 6.5 &#x000d7; 3.7 nm. Although the distance between the last residues of SIRP&#x003b1; and CD47 is only 12.0 nm, our structures do not include the links between the final residues of the extracellular domains and the predicted transmembrane helices, comprising 8 residues in CD47 and 23 residues in SIRP&#x003b1;. Further, the orientation of the complex is constrained by the presence <italic>in vivo</italic> of a disulfide bond between residues Cys<sup>15</sup> and Cys<sup>245</sup> of CD47, the latter being predicted to lie in a 9-residue extracellular loop between the fourth and fifth transmembrane helices of CD47 (<xref ref-type="bibr" rid="B27">27</xref>). It is therefore likely that the distance between cells engaged in a productive CD47-SIRP&#x003b1; interaction will be &#x0223c;14 nm, similar to the cell-cell distances found in other interactions involved in immune recognition, such as MHC-T cell receptor, CD2-CD58, and CD28-CD80 (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>).</p><fig id="F3" position="float"><label>FIGURE 3.</label><caption><p><bold>Model for the CD47-SIRP&#x003b1; complex formed between interacting cells.</bold> The entire extracellular CD47-SIRP&#x003b1; complex, modeled by superposing the structure of SIRP&#x003b1; domains 1&#x02013;3 onto the structure of CD47 in complex with SIRP&#x003b1; domain 1 (<xref ref-type="bibr" rid="B5">5</xref>), is shown as a <italic>blue</italic> (SIRP&#x003b1;) and <italic>yellow</italic> (CD47) molecular surface. Schematic representations of the five transmembrane helices of CD47 (<italic>yellow cylinders</italic>) and single transmembrane helix of SIRP&#x003b1; (<italic>blue cylinder</italic>) are shown. The regions between transmembrane helices and resolved structures for CD47 and SIRP&#x003b1; are illustrated as <italic>dotted lines</italic>. The location of CD47 residue Cys<sup>15</sup>, which forms a disulfide bond with Cys<sup>245</sup> (proposed to reside in the extracellular loop between transmembrane helices 4 and 5), is <italic>highlighted</italic> in <italic>red</italic>.</p></caption><graphic xlink:href="zbc0420989410003"/></fig></sec><sec><title>Relationship of SIRP&#x003b1; d2 and d3 to Ig C1-set Domains</title><sec><title/><sec><title>Overall Features</title><p>At the primary amino acid sequence level, IgSF domains are recognized by characteristic sequence patterns, although the overall sequence identity is often low (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Some features are typical of most IgSF domains, such as the two Cys residues that form a disulfide bridge between the &#x003b2; sheets and a Trp in &#x003b2; strand C that forms part of the hydrophobic core of the domain. The IgSF domain comprises 7&#x02013;9 &#x003b2; strands. V-set domains, which are particularly common in biology and include the domains responsible for antigen recognition, have nine &#x003b2; strands that are identified at the primary sequence level by additional sequence between the two Cys residues. These domains often have other characteristic sequence motifs, such as D<italic>X</italic>(G/A)<italic>X</italic>Y<italic>X</italic>C in &#x003b2; strand F. Domain 1 of the SIRPs is an IgSF V-set domain and contains this sequence motif (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). C1-set domains are discussed below, whereas C2-set domains often share the sequence patterns of V-set domains but are considerably smaller, lacking strands C&#x02033; and D. Further subdivisions of the IgSF, such as the I-set family of domains, have been made on the basis of structural data (<xref ref-type="bibr" rid="B32">32</xref>). SIRP&#x003b1; domains 2 and 3 share the sequence properties that distinguish C1-sets from other IgSF domains. These include the characteristic sequence (F/Y)(F/Y/H)P at the beginning of the BC loop (FSP in d2, FYP in d3) and the sequence <italic>X</italic>V<italic>X</italic>H after the Cys residue in the F strand (<xref ref-type="fig" rid="F4">Fig. 4</xref>). It is interesting to note that the two conserved sequence motifs are in close proximity in the three-dimensional structures of C1-set domains and of SIRP&#x003b1; d2 and d3 (<xref ref-type="fig" rid="F4">Fig. 4</xref>) and may be important in maintaining the C1-set fold. Both d2 and d3 have exactly 13 residues between the Cys in strand B and the Trp in strand C. The presence of 13 residues between these Cys and Trp residues is also highly characteristic of C1-set domains (present in 1242 of 1295 C1-set sequences), whereas it varies in length considerably in V-set domains and C2-set domains (the distance of 13 residues was only found in 14% of 350 IgSF domains from non-antigen receptors) (<xref ref-type="bibr" rid="B33">33</xref>).</p><fig id="F4" position="float"><label>FIGURE 4.</label><caption><p><bold>Structural features conserved across SIRP&#x003b1; d2-d3 and the C1-set family of IgSF domains.</bold><italic>A</italic>, structures of SIRP&#x003b1;, MHC class II, MHC class I (with &#x003b2;2-microglobulin), Fab regions, and Fc regions of IgG are shown as <italic>white ribbons</italic> (with the Protein Data Bank codes indicated in <italic>parentheses</italic>). Conserved residues in the BC and FG loops characteristic of C1-set domains are <italic>colored purple</italic> and <italic>orange</italic>, respectively, disulfide bonds are shown as <italic>yellow spheres</italic>, and conserved residues that form part of the &#x003b2;-sandwich hydrophobic core are <italic>colored light blue. B</italic>, sequence alignments of IgSF C1-set domains illustrated in <italic>A</italic> plus a T-cell receptor &#x003b2; chain constant domain (Protein Data Bank code <ext-link ext-link-type="pdb" xlink:href="1tcr">1tcr</ext-link>). The secondary structure of SIRP&#x003b1; d2 is shown <italic>above</italic> the sequences with <italic>arrows</italic> and <italic>cylinders</italic> representing &#x003b2; sheets and &#x003b1; helices, respectively. Conserved features characteristic of the C1-set family of IgSF domains are <italic>colored</italic> as in <italic>A</italic>.</p></caption><graphic xlink:href="zbc0420989410004"/></fig></sec><sec><title>Structural Homology</title><p>The structural similarity of SIRP&#x003b1; domains 2 and 3 to other IgSF domains was investigated using the protein structure comparison service SSM at the European Bioinformatics Institute (<xref ref-type="bibr" rid="B19">19</xref>) to compare the structures for SIRP&#x003b1; d2 and d3 with panels of V- C1-, C2- and I-set IgSF domains, as classified by the SCOP data base (<xref ref-type="bibr" rid="B20">20</xref>). Searches performed using SIRP&#x003b1; d2 and d3 gave large numbers of hits with the C1-set domains but very few with C2-, V-, or I-set domains (<xref ref-type="table" rid="T2">Table 2</xref> and <xref ref-type="fig" rid="F5">Fig. 5</xref>), comparable with searches performed using <italic>bona fide</italic> C1-set domains. This provides strong evidence that SIRP&#x003b1; d2 and d3 are more similar to C1-set domains than other subsets of IgSF domains. It has been suggested that CD80 domain 2 and lutheran domain 2 also possess C1-set domains (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). However, these structures do not possess the conserved sequence patterns discussed above and do not share structural similarity with large numbers of C1-set IgSF domains (<xref ref-type="table" rid="T2">Table 2</xref>). By comparison, an SSM search of the SCOP-classified IgSF domain panels using SIRP&#x003b1; d1 identified 1128 V-set IgSF domains and 44 I-set domains but no C1- or C2-set domains, consistent with the classification of SIRP&#x003b1; d1 as a V-set IgSF domain and illustrating the specific features of the different subsets. The recent x-ray crystallography structure of tapasin confirmed that it had a C1-set domain (<xref ref-type="bibr" rid="B9">9</xref>). This domain of tapasin gave scores comparable with that of SIRP&#x003b1; d2 or 3 or <italic>bona fide</italic> C1-set (<xref ref-type="table" rid="T2">Table 2</xref>). Tapasin and MHC antigens may be closely related in evolution (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B36">36</xref>).</p><table-wrap id="T2" position="float"><label>TABLE 2</label><caption><p><bold>Similarity of SIRP&#x003b1; domains to other IgSF domain families; SSM analysis</bold></p><p>The number of domains within the families of IgSF as classified in the SCOP database ((20)) that can be overlaid on the query structure with an r.m.s. deviation of 2 &#x0212b; or less is shown (frequency histograms of r.m.s. deviation <italic>versus</italic> SCOP domain for each query are given in <xref ref-type="fig" rid="F5">Fig. 5</xref>). The identification code of each SCOP family is given in parentheses. The regions of the query domains are indicated by residue number (SIRP&#x003b1; d2 and d3), SCOP domain, or Protein Data Bank code with chain and residue numbers.</p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">SCOP families</th><th align="center" rowspan="1" colspan="1">SIRP&#x003b1; d2(115&#x02013;220)</th><th align="center" rowspan="1" colspan="1">SIRP&#x003b1; d3(221&#x02013;317)</th><th align="center" rowspan="1" colspan="1">MHC class II &#x003b2;d2 (d1s9ve1)</th><th align="center" rowspan="1" colspan="1">Ig LC-&#x003ba; d2(1yjd; L:109&#x02013;221)</th><th align="center" rowspan="1" colspan="1">CD80 d2(d1dr9a2)</th><th align="center" rowspan="1" colspan="1">Lutheran d2(2pet; A:115&#x02013;231)</th><th align="center" rowspan="1" colspan="1">Tapasin d2(3f8u; B:270&#x02013;381)</th><th align="center" rowspan="1" colspan="1">VCAM-1 d2(d1vcaa1)</th><th align="center" rowspan="1" colspan="1">SIRP&#x003b1; d1(2uv3; A:1&#x02013;114)</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">V-set (b.1.1.1)</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">13</td><td align="char" char="." rowspan="1" colspan="1">33</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">1,128</td></tr><tr><td align="left" rowspan="1" colspan="1">C1-set (b1.1.2)</td><td align="char" char="." rowspan="1" colspan="1">1,988</td><td align="char" char="." rowspan="1" colspan="1">1,015</td><td align="char" char="." rowspan="1" colspan="1">1,911</td><td align="char" char="." rowspan="1" colspan="1">1,515</td><td align="char" char="." rowspan="1" colspan="1">486</td><td align="char" char="." rowspan="1" colspan="1">127</td><td align="char" char="." rowspan="1" colspan="1">1,031</td><td align="char" char="." rowspan="1" colspan="1">514</td><td align="char" char="." rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">C2-set (b1.1.3)</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">22</td><td align="char" char="." rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">6</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">I-set (b.1.1.4)</td><td align="char" char="." rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">44</td></tr></tbody></table></table-wrap><fig id="F5" position="float"><label>FIGURE 5.</label><caption><p><bold>Similarity of SIRP&#x003b1; domains to IgSF V- and C1-set domains.</bold> SSM superposition C&#x003b1; r.m.s. deviations for query domain structures <italic>versus</italic> the IgSF SCOP families used to generate <xref ref-type="table" rid="T2">Table 2</xref> are shown as frequency histograms in <italic>A</italic> for the V-set (b.1.1.1) and in <italic>B</italic> for the C1-set (b.1.1.2). Frequency intervals of 0.2 &#x0212b; r.m.s. deviation were used.</p></caption><graphic xlink:href="zbc0420989410005"/></fig><p>Structure-based clustering analysis (<xref ref-type="fig" rid="F6">Fig. 6</xref>) demonstrates very clearly that SIRP&#x003b1; d2 and d3 are C1-set IgSF domains, whereas domains 1 from SIRP&#x003b1;, -&#x003b2;, -&#x003b2;(2), and -&#x003b3; are all V-set IgSF domains. Superposition of 46 representative C1-set domains (<xref ref-type="fig" rid="F6">Fig. 6</xref>) shows a striking amount of structural similarity, given the low level of sequence identity shared (<xref ref-type="fig" rid="F4">Fig. 4</xref>). Although the &#x003b2;-sheets that form the core of the domain are well conserved, the loops that connect them are highly divergent. The BC loop is the best conserved of the sheet-connecting loops, consistent with the conserved length and sequence of the BC loop among C1-set domains (see above). Given the high degree of amino acid sequence conservation that SIRP&#x003b2; and SIRP&#x003b3; share with SIRP&#x003b1; (about 90% identity) the d2 and d3 of these proteins will almost certainly also be C1-set IgSF domains.</p><fig id="F6" position="float"><label>FIGURE 6.</label><caption><p><bold>Similarity of SIRP domains to other members of the immunoglobulin superfamily.</bold> Cluster analysis of the structural similarities shared by SIRP&#x003b1; domains 1&#x02013;3; domains 1 of SIRP&#x003b2;, SIRP&#x003b2;(2), and SIRP&#x003b3;; and 277 representative IgSF domains is shown. Each <italic>dot</italic> represents a single IgSF domain, <italic>colored</italic> according to its structural classification within the immunoglobulin superfamily (<italic>red</italic>, V-set; <italic>purple</italic>, C1-set; <italic>blue</italic>, C2-set; <italic>cyan</italic>, I-set; <italic>yellow</italic>, SIRP domains 1; <italic>green</italic>, SIRP&#x003b1; domains 2 and 3; <italic>black</italic>, CD80 d2, VCAM-1 d2, MHC class II &#x003b2; chain d2, Ig &#x003ba; d2, lutheran d2, and tapasin d2). The distance between domains is proportional to their structural similarity (see &#x0201c;Experimental Procedures&#x0201d;). Superposed C1-set and V-set structures are shown as C&#x003b1; traces, <italic>color-ramped</italic> from <italic>blue</italic> (start of domain) to <italic>red</italic> (end of domain).</p></caption><graphic xlink:href="zbc0420989410006"/></fig></sec></sec></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><sec><title/><sec><title/><sec><title>The Dimensions of the CD47-SIRP&#x003b1; Interaction Are Compatible with the Immunological Synapse</title><p>The structure of SIRP&#x003b1; indicated that the CD47-SIRP&#x003b1; interaction is likely to span &#x0223c;14 nm. This is the distance spanned by well characterized components of the immunological synapse. Since SIRP&#x003b1; is present on macrophages and neurons and its ligand CD47 is present on most cell types, it seems likely that productive engagement of SIRP&#x003b1; by CD47 will occur only at regions of close contact, analogous to the immunological synapse, as shown for phagocytosis of red blood cells (<xref ref-type="bibr" rid="B37">37</xref>). It is likely that these CD47-SIRP&#x003b1;-containing synapse-like interactions will occur between many cell types, as also suggested previously in the case of the CD200-CD200R interaction (<xref ref-type="bibr" rid="B38">38</xref>).</p></sec><sec><title>Implications for the Evolution of Antigen Receptors</title><p>During vertebrate evolution the adaptive immune system developed into that of mammals today, one that can generate a diverse set of T cell receptors and immunoglobulins to recognize a vast number of different antigens through rearrangement of gene segments and a recognition system involving MHC antigens. Most of these components are present in jawed but not in jawless fish, and there is considerable interest in how these proteins evolved. Characteristic IgSF C1-set domains are present exclusively in antigen receptors and certain proteins closely associated with antigen recognition, such as MHC antigens, tapasin, and &#x003b2;2-microglobulin. Our structure shows that domains 2 and 3 of SIRP&#x003b1; are C1-set domains, strengthening suggestions based on sequence analysis that the SIRPs are closely related to the precursors of antigen receptors (<xref ref-type="bibr" rid="B8">8</xref>). C1-set domains are always found in association with other domains, with <italic>cis</italic> interactions being present between heavy- and light-chain constant domains in antibodies, &#x003b2;2-microglobulin and the C1-set domain in MHC Class I and related proteins, the two domains in MHC class II, and the adjacent chains in the T cell receptors. Within T cell receptor and Ig, C1-set domains are C-terminal to the V-set domain and present as linear arrays in Ig H chains. The SIRPs maintain this linear array and the V-set-C1-set topology.</p><p>No SIRP genes have been identified in organisms predating the adaptive immune system (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B39">39</xref>); thus, one cannot distinguish between SIRPs evolving directly from a precursor of the antigen receptors or from an antigen receptor itself. However, it seems reasonable that the primitive antigen receptor was expressed on myeloid cells and contained both V- and C1-set IgSF domains.</p></sec></sec></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="PMC_1" content-type="local-data"><caption><title>Supplemental Data</title></caption><media mimetype="text" mime-subtype="html" xlink:href="supp_284_39_26613__index.html"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="supp_M109.017566_jbc.M109.017566-1.pdf"/><media xlink:role="associated-file" mimetype="video" mime-subtype="mpeg" xlink:href="supp_M109.017566_jbc.M109.017566-2.mpg"/></supplementary-material></sec></body><back><fn-group><fn fn-type="supported-by" id="FN1"><label>*</label><p>This work was supported in part by Medical Research Council Grant G0400808 and Wellcome Trust Grant WT084194 (to A. N. B., D. H., K. H., D. I. S., and the Oxford Protein Production Facility). This is a contribution of the European Community project SPINE2-Complexes (LSHG-CT-2006-031220).</p></fn><fn fn-type="other"><p>The atomic coordinates and structure factors (code <ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/pdb/explore/explore.do?structureId=2WNG">2WNG</ext-link>) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (<ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/">http://www.rcsb.org/</ext-link>).</p></fn><fn fn-type="supplementary-material" id="FN2"><label><inline-graphic xlink:href="sbox.jpg"/></label><p> The on-line version of this article (available at <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org">http://www.jbc.org</ext-link>) contains <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.017566/DC1">supplemental Fig. S1</ext-link>.</p></fn><fn fn-type="other" id="FN5"><label>5</label><p>G. Winter, manuscript in preparation.</p></fn></fn-group><fn-group content-type="abbreviations"><fn id="FN4"><label>4</label><p>The abbreviations used are: <def-list><def-item><term id="G1">SIRP</term><def><p>signal-regulatory protein</p></def></def-item><def-item><term id="G2">IgSF</term><def><p>immunoglobulin superfamily</p></def></def-item><def-item><term id="G3">MHC</term><def><p>major histocompatibility complex</p></def></def-item><def-item><term id="G4">r.m.s.</term><def><p>root mean square</p></def></def-item><def-item><term id="G5">SSM</term><def><p>secondary structure matching.</p></def></def-item></def-list></p></fn></fn-group><ack><title>Acknowledgments</title><p>We are grateful to the staff of beamline ID14-2 at the European Synchrotron Radiation Facility for assistance with data collection and to T. S. Walter for assistance with crystallization.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barclay</surname><given-names>A. N.</given-names></name><name><surname>Brown</surname><given-names>M. H.</given-names></name></person-group> (<year>2006</year>) <source>Nat. Rev. Immunol.</source><volume>6</volume>, <fpage>457</fpage>&#x02013;<lpage>464</lpage><pub-id pub-id-type="pmid">16691243</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>E. J.</given-names></name><name><surname>Frazier</surname><given-names>W. A.</given-names></name></person-group> (<year>2001</year>) <source>Trends Cell Biol.</source><volume>11</volume>, <fpage>130</fpage>&#x02013;<lpage>135</lpage><pub-id pub-id-type="pmid">11306274</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oldenborg</surname><given-names>P. A.</given-names></name><name><surname>Zheleznyak</surname><given-names>A.</given-names></name><name><surname>Fang</surname><given-names>Y. F.</given-names></name><name><surname>Lagenaur</surname><given-names>C. F.</given-names></name><name><surname>Gresham</surname><given-names>H. D.</given-names></name><name><surname>Lindberg</surname><given-names>F. P.</given-names></name></person-group> (<year>2000</year>) <source>Science</source><volume>288</volume>, <fpage>2051</fpage>&#x02013;<lpage>2054</lpage><pub-id pub-id-type="pmid">10856220</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujioka</surname><given-names>Y.</given-names></name><name><surname>Matozaki</surname><given-names>T.</given-names></name><name><surname>Noguchi</surname><given-names>T.</given-names></name><name><surname>Iwamatsu</surname><given-names>A.</given-names></name><name><surname>Yamao</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Tsuda</surname><given-names>M.</given-names></name><name><surname>Takada</surname><given-names>T.</given-names></name><name><surname>Kasuga</surname><given-names>M.</given-names></name></person-group> (<year>1996</year>) <source>Mol. Cell. Biol.</source><volume>16</volume>, <fpage>6887</fpage>&#x02013;<lpage>6899</lpage><pub-id pub-id-type="pmid">8943344</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatherley</surname><given-names>D.</given-names></name><name><surname>Graham</surname><given-names>S. C.</given-names></name><name><surname>Turner</surname><given-names>J.</given-names></name><name><surname>Harlos</surname><given-names>K.</given-names></name><name><surname>Stuart</surname><given-names>D. I.</given-names></name><name><surname>Barclay</surname><given-names>A. N.</given-names></name></person-group> (<year>2008</year>) <source>Mol. Cell</source><volume>31</volume>, <fpage>266</fpage>&#x02013;<lpage>277</lpage><pub-id pub-id-type="pmid">18657508</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatherley</surname><given-names>D.</given-names></name><name><surname>Harlos</surname><given-names>K.</given-names></name><name><surname>Dunlop</surname><given-names>D. C.</given-names></name><name><surname>Stuart</surname><given-names>D. I.</given-names></name><name><surname>Barclay</surname><given-names>A. N.</given-names></name></person-group> (<year>2007</year>) <source>J. Biol. Chem.</source><volume>282</volume>, <fpage>14567</fpage>&#x02013;<lpage>14575</lpage><pub-id pub-id-type="pmid">17369261</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J. H.</given-names></name><name><surname>Smolyar</surname><given-names>A.</given-names></name><name><surname>Tan</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>Z. Y.</given-names></name><name><surname>Wagner</surname><given-names>G.</given-names></name><name><surname>Reinherz</surname><given-names>E. L.</given-names></name></person-group> (<year>1999</year>) <source>Cell</source><volume>97</volume>, <fpage>791</fpage>&#x02013;<lpage>803</lpage><pub-id pub-id-type="pmid">10380930</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Berg</surname><given-names>T. K.</given-names></name><name><surname>Yoder</surname><given-names>J. A.</given-names></name><name><surname>Litman</surname><given-names>G. W.</given-names></name></person-group> (<year>2004</year>) <source>Trends Immunol.</source><volume>25</volume>, <fpage>11</fpage>&#x02013;<lpage>16</lpage><pub-id pub-id-type="pmid">14698279</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>G.</given-names></name><name><surname>Wearsch</surname><given-names>P. A.</given-names></name><name><surname>Peaper</surname><given-names>D. R.</given-names></name><name><surname>Cresswell</surname><given-names>P.</given-names></name><name><surname>Reinisch</surname><given-names>K. M.</given-names></name></person-group> (<year>2009</year>) <source>Immunity</source><volume>30</volume>, <fpage>21</fpage>&#x02013;<lpage>32</lpage><pub-id pub-id-type="pmid">19119025</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>T. S.</given-names></name><name><surname>Diprose</surname><given-names>J. M.</given-names></name><name><surname>Mayo</surname><given-names>C. J.</given-names></name><name><surname>Siebold</surname><given-names>C.</given-names></name><name><surname>Pickford</surname><given-names>M. G.</given-names></name><name><surname>Carter</surname><given-names>L.</given-names></name><name><surname>Sutton</surname><given-names>G. C.</given-names></name><name><surname>Berrow</surname><given-names>N. S.</given-names></name><name><surname>Brown</surname><given-names>J.</given-names></name><name><surname>Berry</surname><given-names>I. M.</given-names></name><name><surname>Stewart-Jones</surname><given-names>G. B.</given-names></name><name><surname>Grimes</surname><given-names>J. M.</given-names></name><name><surname>Stammers</surname><given-names>D. K.</given-names></name><name><surname>Esnouf</surname><given-names>R. M.</given-names></name><name><surname>Jones</surname><given-names>E. Y.</given-names></name><name><surname>Owens</surname><given-names>R. J.</given-names></name><name><surname>Stuart</surname><given-names>D. I.</given-names></name><name><surname>Harlos</surname><given-names>K.</given-names></name></person-group> (<year>2005</year>) <source>Acta Crystallogr. D Biol. Crystallogr.</source><volume>61</volume>, <fpage>651</fpage>&#x02013;<lpage>657</lpage><pub-id pub-id-type="pmid">15930615</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabsch</surname><given-names>W.</given-names></name></person-group> (<year>1993</year>) <source>J. Appl. Crystallogr.</source><volume>26</volume>, <fpage>795</fpage>&#x02013;<lpage>800</lpage></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>P. R.</given-names></name></person-group> (<year>2005</year>) <source>Acta Crystallogr. D Biol. Crystallogr.</source><volume>62</volume>, <fpage>72</fpage>&#x02013;<lpage>82</lpage><pub-id pub-id-type="pmid">16369096</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vagin</surname><given-names>A.</given-names></name><name><surname>Teplyakov</surname><given-names>A.</given-names></name></person-group> (<year>1997</year>) <source>J. Appl. Crystallogr.</source><volume>30</volume>, <fpage>1022</fpage>&#x02013;<lpage>1025</lpage></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P.</given-names></name><name><surname>Cowtan</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>) <source>Acta Crystallogr. D Biol. Crystallogr.</source><volume>60</volume>, <fpage>2126</fpage>&#x02013;<lpage>2132</lpage><pub-id pub-id-type="pmid">15572765</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Afonine</surname><given-names>P. V.</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name><name><surname>Adams</surname><given-names>P. D.</given-names></name></person-group> (<year>2005</year>) <source>CCP4 Newsletter</source><volume>42</volume>, <publisher-name>contribution 8, Daresbury Laboratory</publisher-name>, <publisher-loc>Warrington, UK</publisher-loc></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanc</surname><given-names>E.</given-names></name><name><surname>Roversi</surname><given-names>P.</given-names></name><name><surname>Vonrhein</surname><given-names>C.</given-names></name><name><surname>Flensburg</surname><given-names>C.</given-names></name><name><surname>Lea</surname><given-names>S. M.</given-names></name><name><surname>Bricogne</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>) <source>Acta Crystallogr. D Biol. Crystallogr.</source><volume>60</volume>, <fpage>2210</fpage>&#x02013;<lpage>2221</lpage><pub-id pub-id-type="pmid">15572774</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tronrud</surname><given-names>D.</given-names></name></person-group> (<year>1996</year>) <source>J. Appl. Crystallogr.</source><volume>29</volume>, <fpage>100</fpage>&#x02013;<lpage>104</lpage></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovell</surname><given-names>S. C.</given-names></name><name><surname>Davis</surname><given-names>I. W.</given-names></name><name><surname>Arendall</surname><given-names>W. B.</given-names><suffix>3rd</suffix></name><name><surname>de Bakker</surname><given-names>P. I.</given-names></name><name><surname>Word</surname><given-names>J. M.</given-names></name><name><surname>Prisant</surname><given-names>M. G.</given-names></name><name><surname>Richardson</surname><given-names>J. S.</given-names></name><name><surname>Richardson</surname><given-names>D. C.</given-names></name></person-group> (<year>2003</year>) <source>Proteins</source><volume>50</volume>, <fpage>437</fpage>&#x02013;<lpage>450</lpage><pub-id pub-id-type="pmid">12557186</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krissinel</surname><given-names>E.</given-names></name><name><surname>Henrick</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>) <source>Acta Crystallogr. D Biol. Crystallogr.</source><volume>60</volume>, <fpage>2256</fpage>&#x02013;<lpage>2268</lpage><pub-id pub-id-type="pmid">15572779</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murzin</surname><given-names>A. G.</given-names></name><name><surname>Brenner</surname><given-names>S. E.</given-names></name><name><surname>Hubbard</surname><given-names>T.</given-names></name><name><surname>Chothia</surname><given-names>C.</given-names></name></person-group> (<year>1995</year>) <source>J. Mol. Biol.</source><volume>247</volume>, <fpage>536</fpage>&#x02013;<lpage>540</lpage><pub-id pub-id-type="pmid">7723011</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandonia</surname><given-names>J. M.</given-names></name><name><surname>Hon</surname><given-names>G.</given-names></name><name><surname>Walker</surname><given-names>N. S.</given-names></name><name><surname>Lo Conte</surname><given-names>L.</given-names></name><name><surname>Koehl</surname><given-names>P.</given-names></name><name><surname>Levitt</surname><given-names>M.</given-names></name><name><surname>Brenner</surname><given-names>S. E.</given-names></name></person-group> (<year>2004</year>) <source>Nucleic Acids Res.</source><volume>32</volume>, <fpage>D189</fpage>&#x02013;<lpage>D192</lpage><pub-id pub-id-type="pmid">14681391</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fruchterman</surname><given-names>T.</given-names></name><name><surname>Reingold</surname><given-names>E.</given-names></name></person-group> (<year>1991</year>) <source>Software Practice Experience</source><volume>21</volume>, <fpage>1129</fpage>&#x02013;<lpage>1164</lpage></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frickey</surname><given-names>T.</given-names></name><name><surname>Lupas</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>) <source>Bioinformatics</source><volume>20</volume>, <fpage>3702</fpage>&#x02013;<lpage>3704</lpage><pub-id pub-id-type="pmid">15284097</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theobald</surname><given-names>D. L.</given-names></name><name><surname>Wuttke</surname><given-names>D. S.</given-names></name></person-group> (<year>2006</year>) <source>Bioinformatics</source><volume>22</volume>, <fpage>2171</fpage>&#x02013;<lpage>2172</lpage><pub-id pub-id-type="pmid">16777907</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>P.</given-names></name></person-group> (<year>1989</year>) <source>Mol. Cell. Biol.</source><volume>9</volume>, <fpage>377</fpage>&#x02013;<lpage>383</lpage><pub-id pub-id-type="pmid">2710109</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>S. J.</given-names></name><name><surname>Puklavec</surname><given-names>M. J.</given-names></name><name><surname>Ashford</surname><given-names>D. A.</given-names></name><name><surname>Harlos</surname><given-names>K.</given-names></name><name><surname>Jones</surname><given-names>E. Y.</given-names></name><name><surname>Stuart</surname><given-names>D. I.</given-names></name><name><surname>Williams</surname><given-names>A. F.</given-names></name></person-group> (<year>1993</year>) <source>Protein Eng.</source><volume>6</volume>, <fpage>229</fpage>&#x02013;<lpage>232</lpage><pub-id pub-id-type="pmid">8097313</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebres</surname><given-names>R. A.</given-names></name><name><surname>Vaz</surname><given-names>L. E.</given-names></name><name><surname>Green</surname><given-names>J. M.</given-names></name><name><surname>Brown</surname><given-names>E. J.</given-names></name></person-group> (<year>2001</year>) <source>J. Biol. Chem.</source><volume>276</volume>, <fpage>34607</fpage>&#x02013;<lpage>34616</lpage><pub-id pub-id-type="pmid">11454874</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garboczi</surname><given-names>D. N.</given-names></name><name><surname>Ghosh</surname><given-names>P.</given-names></name><name><surname>Utz</surname><given-names>U.</given-names></name><name><surname>Fan</surname><given-names>Q. R.</given-names></name><name><surname>Biddison</surname><given-names>W. E.</given-names></name><name><surname>Wiley</surname><given-names>D. C.</given-names></name></person-group> (<year>1996</year>) <source>Nature</source><volume>384</volume>, <fpage>134</fpage>&#x02013;<lpage>141</lpage><pub-id pub-id-type="pmid">8906788</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>E. J.</given-names></name><name><surname>Esnouf</surname><given-names>R. M.</given-names></name><name><surname>Manso-Sancho</surname><given-names>R.</given-names></name><name><surname>Gilbert</surname><given-names>R. J.</given-names></name><name><surname>James</surname><given-names>J. R.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Fennelly</surname><given-names>J. A.</given-names></name><name><surname>Vowles</surname><given-names>C.</given-names></name><name><surname>Hanke</surname><given-names>T.</given-names></name><name><surname>Walse</surname><given-names>B.</given-names></name><name><surname>H&#x000fc;nig</surname><given-names>T.</given-names></name><name><surname>S&#x000f8;rensen</surname><given-names>P.</given-names></name><name><surname>Stuart</surname><given-names>D. I.</given-names></name><name><surname>Davis</surname><given-names>S. J.</given-names></name></person-group> (<year>2005</year>) <source>Nat. Immunol.</source><volume>6</volume>, <fpage>271</fpage>&#x02013;<lpage>279</lpage><pub-id pub-id-type="pmid">15696168</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barclay</surname><given-names>A. N.</given-names></name></person-group> (<year>2003</year>) <source>Semin. Immunol.</source><volume>15</volume>, <fpage>215</fpage>&#x02013;<lpage>223</lpage><pub-id pub-id-type="pmid">14690046</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>A. F.</given-names></name><name><surname>Barclay</surname><given-names>A. N.</given-names></name></person-group> (<year>1988</year>) <source>Annu. Rev. Immunol.</source><volume>6</volume>, <fpage>381</fpage>&#x02013;<lpage>405</lpage><pub-id pub-id-type="pmid">3289571</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harpaz</surname><given-names>Y.</given-names></name><name><surname>Chothia</surname><given-names>C.</given-names></name></person-group> (<year>1994</year>) <source>J. Mol. Biol.</source><volume>238</volume>, <fpage>528</fpage>&#x02013;<lpage>539</lpage><pub-id pub-id-type="pmid">8176743</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>D. K.</given-names></name><name><surname>Xue</surname><given-names>H.</given-names></name></person-group> (<year>1997</year>) <source>J. Mol. Biol.</source><volume>274</volume>, <fpage>530</fpage>&#x02013;<lpage>545</lpage><pub-id pub-id-type="pmid">9417933</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mankelow</surname><given-names>T. J.</given-names></name><name><surname>Burton</surname><given-names>N.</given-names></name><name><surname>Stefansdottir</surname><given-names>F. O.</given-names></name><name><surname>Spring</surname><given-names>F. A.</given-names></name><name><surname>Parsons</surname><given-names>S. F.</given-names></name><name><surname>Pedersen</surname><given-names>J. S.</given-names></name><name><surname>Oliveira</surname><given-names>C. L.</given-names></name><name><surname>Lammie</surname><given-names>D.</given-names></name><name><surname>Wess</surname><given-names>T.</given-names></name><name><surname>Mohandas</surname><given-names>N.</given-names></name><name><surname>Chasis</surname><given-names>J. A.</given-names></name><name><surname>Brady</surname><given-names>R. L.</given-names></name><name><surname>Anstee</surname><given-names>D. J.</given-names></name></person-group> (<year>2007</year>) <source>Blood</source><volume>110</volume>, <fpage>3398</fpage>&#x02013;<lpage>3406</lpage><pub-id pub-id-type="pmid">17638854</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikemizu</surname><given-names>S.</given-names></name><name><surname>Gilbert</surname><given-names>R. J.</given-names></name><name><surname>Fennelly</surname><given-names>J. A.</given-names></name><name><surname>Collins</surname><given-names>A. V.</given-names></name><name><surname>Harlos</surname><given-names>K.</given-names></name><name><surname>Jones</surname><given-names>E. Y.</given-names></name><name><surname>Stuart</surname><given-names>D. I.</given-names></name><name><surname>Davis</surname><given-names>S. J.</given-names></name></person-group> (<year>2000</year>) <source>Immunity</source><volume>12</volume>, <fpage>51</fpage>&#x02013;<lpage>60</lpage><pub-id pub-id-type="pmid">10661405</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>W. E.</given-names></name><name><surname>Klein</surname><given-names>J.</given-names></name></person-group> (<year>2001</year>) <source>Immunogenetics</source><volume>53</volume>, <fpage>719</fpage>&#x02013;<lpage>723</lpage><pub-id pub-id-type="pmid">11862402</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>R. K.</given-names></name><name><surname>Discher</surname><given-names>D. E.</given-names></name></person-group> (<year>2008</year>) <source>J. Cell Biol.</source><volume>180</volume>, <fpage>989</fpage>&#x02013;<lpage>1003</lpage><pub-id pub-id-type="pmid">18332220</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>G. J.</given-names></name><name><surname>Puklavec</surname><given-names>M. J.</given-names></name><name><surname>Willis</surname><given-names>A. C.</given-names></name><name><surname>Hoek</surname><given-names>R. M.</given-names></name><name><surname>Sedgwick</surname><given-names>J. D.</given-names></name><name><surname>Brown</surname><given-names>M. H.</given-names></name><name><surname>Barclay</surname><given-names>A. N.</given-names></name></person-group> (<year>2000</year>) <source>Immunity</source><volume>13</volume>, <fpage>233</fpage>&#x02013;<lpage>242</lpage><pub-id pub-id-type="pmid">10981966</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Beek</surname><given-names>E. M.</given-names></name><name><surname>Cochrane</surname><given-names>F.</given-names></name><name><surname>Barclay</surname><given-names>A. N.</given-names></name><name><surname>van den Berg</surname><given-names>T. K.</given-names></name></person-group> (<year>2005</year>) <source>J. Immunol.</source><volume>175</volume>, <fpage>7781</fpage>&#x02013;<lpage>7787</lpage><pub-id pub-id-type="pmid">16339510</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diederichs</surname><given-names>K.</given-names></name><name><surname>Karplus</surname><given-names>P. A.</given-names></name></person-group> (<year>1997</year>) <source>Nat. Struct. Biol.</source><volume>4</volume>, <fpage>269</fpage>&#x02013;<lpage>275</lpage><pub-id pub-id-type="pmid">9095194</pub-id></mixed-citation></ref></ref-list></back></article>